Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Verastem Inc chart...

About the Company

verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com

CEO

Brian Stuglik

Exchange

NASDAQ

Website

http://www.verastem.com/

$4M

Total Revenue

74

Employees

$281M

Market Capitalization

-29.50

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VSTM News

Verastem: Q4 Earnings Snapshot

4d ago, source: The Washington Post

NEEDHAM, Mass. — NEEDHAM, Mass. — Verastem Inc. (VSTM) on Thursday reported a loss of $27.4 million in its fourth quarter. The Needham, Massachusetts-based company said it had a loss of $1.02 ...

Analysts’ Top Healthcare Picks: Verastem (VSTM), Akebia Therapeutics (AKBA)

2d ago, source: Business Insider

Verastem (VSTM) BTIG analyst Justin Zelin reiterated a Buy ... Rani Therapeutics Holdings, and Apogee Therapeutics, Inc. The word on The Street in general, suggests a Strong Buy analyst consensus ...

Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates

4d ago, source:

NDAQ:VSTM) Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates ...

Verastem, Inc. (VSTM) stock price, news, quote & history – Yahoo Finance

8d ago, source: Yahoo Finance

BOSTON, March 11, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced multiple oral and poster ...

Verastem: Q4 Earnings Snapshot

4d ago, source:

NEEDHAM, Mass. (AP) — NEEDHAM, Mass. (AP) — Verastem Inc. (VSTM) on Thursday reported a loss of $27.4 million in its fourth quarter. The Needham, Massachusetts-based company said it had a loss of ...

Verastem, Inc. (VSTM) stock price, news, quote & history – Yahoo Finance

7d ago, source: Yahoo Finance

This strategic move has expanded Viking Global's holding to a total of 2,531,829 shares in Verastem Inc, reflecting the firm's confidence in the company's future prospects.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...